High-throughput sequencing techniques are used to analyse the diversity of the respiratory microbiota in health and disease. Although extensive data are available regarding bacterial respiratory microbiota, its fungal component remains poorly studied. This is partly due to the technical issues associated with fungal metagenomics analyses. In this study, we compared two DNA extraction protocols and two fungal amplification targets for combined bacterial and fungal targeted amplicon sequencing analyses of the respiratory microbiota.
Six sputa, randomly selected from routine samples in Mondor Hospital (Creteil, France) and treated anonymously, were tested after bacterial and fungal routine culture. Two of which were spiked with Aspergillus Fumigati and Aspergillus Nigri (105 conidia/mL). After mechanical lysis, DNA was extracted using automated QIAsymphony® extraction (AQE) or manual PowerSoil® MoBio extraction (MPE). DNA yield and purity were compared. DNA extracted from spiked sputa was subjected to (i) real-time PCR for Aspergillus DNA detection and (ii) combined metagenomic analyses targeting barcoded primers for fungal ITS1 and ITS2, and bacterial V1-V2 and V3-V4 16S regions. Amplicon libraries were prepared using MiSeq Reagent V3 kit on Illumina platform. Data were analysed using PyroMIC© and SHAMAN software, and compared with culture results.
AQE extraction provided a higher yield of DNA (AQE/MPE DNA ratio = 4.5 [1.3–11]) in a shorter time. The yield of Aspergillus DNA detected by qPCR was similar for spiked sputa regardless of extraction protocol. The extraction moderately impacted the diversity or relative abundances of bacterial communities using targeted amplicon sequencing (2/43 taxa impacted). For fungi, the relative abundances of 4/11 major taxa were impacted and AQE results were closer to culture results. The V1-V2 or V3-V4 and ITS1 or ITS2 targets assessed similarly the diversity of bacterial and fungal major taxa, but ITS2 and V3-V4 detected more minor taxa.
Our results showed the importance of DNA extraction for combined bacterial and fungal targeted metagenomics of respiratory samples. The extraction protocol can affect DNA yield and the relative abundances of few bacterial but more fungal taxa. For fungal analysis, ITS2 allowed the detection of a greater number of minor taxa compared with ITS1.
Citation: Angebault C, Payen M, Woerther P-L, Rodriguez C, Botterel F (2020) Combined bacterial and fungal targeted amplicon sequencing of respiratory samples: Does the DNA extraction method matter? PLoS ONE 15(4): e0232215. https://doi.org/10.1371/journal.pone.0232215
Editor: Joy Sturtevant, Louisiana State University, UNITED STATES
Received: November 8, 2019; Accepted: April 9, 2020; Published: April 28, 2020
Copyright: © 2020 Angebault et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: Raw data are available on Genbank NCBI NIH (SRA accession number: PRJNA548447; https://www.ncbi.nlm.nih.gov/sra/PRJNA548447). All other relevant data are within the manuscript and its Supporting Information files.
Funding: This work is an ancillary project of a larger study entitled "Ecologie et dynamique des communautés bactériennes et fongiques des voies aériennes supérieures des patients atteints de mucoviscidose: Exploration prospective des discordances clinico-biologiques lors des traitements anti-infectieux par pyroséquençage à haut débit”, which received a grant from “Vaincre La Mucoviscidose” Fondation (Grant Number attributed to FB: 2013/2013-047/03, https://www.vaincrelamuco.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: I have read the journal's policy and the authors of this manuscript have the following competing interests: FB received grants from Astellas, and payment for lectures from Merck. CA received a travel grant from MSD France in 2017. MP, PLW, CR declare no conflict of interest. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
The human respiratory microbiota is a complex ecosystem extending from the nasopharyngeal cavities to the alveoli. It comprises a vast community of microorganisms distributed with relatively variable gradients depending on the site . In this ecosystem, bacteria (e.g. Streptococcus, Veillonella or Prevotella) are the most represented besides fungi, viruses, and archaea. With the development of high throughput sequencing enabling 16S/ITS targeted amplicon high-throughput sequencing and metagenomics, the bacterial component of human respiratory microbiota has become under increasing scrutiny to understand its role in health and disease [1–5]. Lately, it has become evident that the fungal microbiota (mycobiota) should be concomitantly studied to better understand trans-kingdom interactions and the role of fungi in the respiratory pathogenesis. A prerequisite to obtain comparable representations of the microbial communities using high-throughput sequencing methods is the use of appropriate protocols, especially for DNA extraction. The impact of extraction on DNA yield or quality and on community composition has been evaluated in several studies focusing mainly on the digestive bacterial microbiota [6–11]. However, little is known regarding extraction protocols appropriate for fungal analysis or combined bacterial and fungal analyses, especially in case of respiratory microbiota [6,8,12–15]. The technical issues associated with fungal high-throughput sequencing analysis arise from the scarce presence of fungi in the biosphere and from the complex nature of their cell wall . The latter is composed of a thick layer of chitin, beta-glucans, lipids, and peptides with sometimes additional melanin , which protects the fungal cell from enzymatic or chemical lysis (an essential step in DNA extraction) . Another issue concerns the choice of the DNA amplification target. Most mycobiota studies have targeted the internal transcribed spacer (ITS) region, as recommended by the Fungal Barcoding Consortium , and most authors chose ITS1 [14,15,19–21] rather than ITS2 region [2,3]. Deciding which is better remains uncertain, though ITS1 database is broader than that of ITS2 [14,22]. In the present study, we compared the impact of two recent extraction protocols: the commonly used manual PowerSoil® MoBio extraction (MPE), and the automated QIAsymphony extraction (AQE) using DSP DNA Midi kit, on the fungal and bacterial diversity where both communities were concomitantly assessed via 16S/ITS targeted amplicon sequencing in respiratory samples. We also compared the diversity of (i) fungal community using amplification with ITS1 or ITS2 regions and of (ii) bacterial community using V1-V2 or V3-V4 16S regions. As 16S/ITS targeted amplicon sequencing and culture analyses are rarely performed concomitantly, although it seems essential in a medical laboratory context, we also compared sequencing with culture results.
Materials and methods
Sample collection, culture
Six sputa from patients (P1, P2, P3, P4, P5, and P6) hospitalized in Henri Mondor University Hospital (Créteil, France) were randomly selected from sputa addressed to the microbiological laboratory after assessment of their quality according to Murray and Washington criteria . As part of routine bacterial analysis, they were inoculated onto Chocolate agar + PolyViteX, Columbia agar + 5% horse blood, Columbia ANC agar + 5% sheep blood, Trypicase Soy Agar and Drigalski agar (bioMérieux, Marcy L’Etoile, France) for 48h to 5 days at 35°C. After inclusion in our study, two sputa (P1 and P2) were spiked with 105 conidia of Aspergillus section Fumigati and 105 conidia of Aspergillus section Nigri. Ten microliters of the two spiked-sputa (P1 and P2) were inoculated onto two Sabouraud-Chloramphenicol-Gentamicin slants (Bio-rad, Marnes-la-Coquette, France) and onto one BBLTM CHROMagarTM Candida plate (Beckton Dickinson, Le Pont de Claix, France). Sabouraud slants were incubated for 21 days at 30°C or 35°C and CHROMagarTM Candida plate for 72h at 35°C. All sputa were divided into aliquots of 250 mg each and stored at -20°C for DNA extraction (Fig 1). This work was part of MucoBacMyco project, which was approved by an ad hoc Ethics Committee named Comité de Protection des Personnes d’Ile de France IX (N° CPP-IDF IX-12-011).
A- Comparison of two DNA extraction protocols (automated QIAsymphony extraction [AQE] using DSP DNA midi kit and manual PowerSoil® MoBio extraction [MPE]) in terms of quantity and quality of DNA extracted from 6 sputa (6 patients, P1, P2, P3, P4, P5, P6). B- Comparison of bacterial and fungal diversity detected in two sputa (2 patients, P1, P2) spiked with 105 conidia of Aspergillus section Fumigati and Aspergillus section Nigri using (i) culture method and (ii) 16S/ITS targeted amplicon sequencing (DNA extracted using AQE or MPE protocols; amplification targets V1-V2 and V3-V4 16S for bacteria, and ITS2 and ITS2 for fungi; MiSeq® Illumina, 2x300 v3 kit).
DNA extraction protocols
All samples (250 mg aliquots) stored at -20°C were subjected to two different genomic DNA extraction protocols (Manual Powersoil® extraction -MPE- and Automated QIAsymphony extraction -AQE, see below). Negative extraction controls (250 μL DNA-free water) were processed in the same way as samples.
Manual Powersoil® extraction (MPE), MoBio PowerLyzer PowerSoil® DNA Isolation kit (QIAGEN, Carlsbad, USA).
The aliquots were pipetted into PowerLyzer® 0.1 mm Glass Bead Tubes and submitted to mechanical lysis: two 60-sec cycles at 6400 rpm on MagNA Lyser Instrument (Roche, Mannheim, Germany) and 1 min rest on ice between cycles. We then proceeded as per manufacturer’s instructions with minor adjustments: centrifugation of the Glass Bead Tubes for 5 mins instead of 30 secs (step 7 of the protocol, after mechanical lysis) and 5 mins waiting at room temperature (instead of 30 secs) before spinning at 10000g for 1 min (step 22) .
Automated QIAsymphony extraction (AQE), DSP DNA midi kit (QIAGEN, Carlsbad, USA).
The aliquots were diluted in 450 μL of ATL buffer (QIAGEN, Carlsbad, USA) and mixed with 1.4 mm ceramic MagNA Lyser green beads before mechanical lysis (as described above). They were centrifuged 3 mins at 10000g, and 450μL of supernatant was transferred to a new tube for enzymatic lysis (25μL of Proteinase K (Thermo Fisher Scientific, Courtaboeuf, France), for 45 minutes, at 56°C). The aliquots were submitted to automated extraction on the QIAsymphony using DSP DNA midi kit as recommended by the manufacturer.
Nucleic acid quantification
The evaluation of DNA quality, and especially of RNA significant contamination, was performed using agar electrophoresis of DNA samples (1% agarose gel, 100V 30-minute migration). Extracted DNAs were quantified using Thermo ScientificTM NanodropTM 2000 spectophotometer (Thermo Fisher Scientific, Courtaboeuf, France), and Quant-iT PicoGreen dsDNA Assay Kit (Invitogren, Carlsbad, USA).
Aspergillus DNA detection by real-time PCR in spiked sputa
The DNA extracts of the spiked sputa were analysed for Aspergillus DNA detection using real-time PCR targeting the 28S region of A. fumigatus  and the mitochondrial DNA of Aspergillus sp . PCR was performed on a StepOnePlus System (Applied Biosystems, Foster City, USA).
PCR amplification and sequencing
Amplicon libraries targeting V1-V2 or V3-V4 16S hyper-variable regions for bacteria and ITS1 or ITS2 regions for fungi were prepared. The employed 16S primers (for V1-V2: primers 27 and 338; for V3-V4: primers 341 and 785 without degenerate nucleotides [7,26]) were those recommended in the 16S Metagenomic Sequencing Library Preparation guide  (http://emea.support.illumina.com). The ITS1 primers were ITS1F [28,29] and ITS2; the ITS2, primers were ITS3 and ITS4 , all after inclusion of the Illumina sequencing adapters . PCR amplicons were generated using Veriti™ Thermal Cycler (Applied Biosystems, Foster City, USA) in the following conditions: 3 mins at 95°C denaturation; 35 cycles (94°C for 30 secs, 53°C for 30 secs, and 72°C for 30 secs), and 5 mins at 72°C final elongation before cooling at 4°C. Positive controls consisting in DNA from Escherichia and Candida and negative controls were used for V1-V2 and V3-V4 16S, ITS1 and ITS2 amplifications, respectively. Each sample was purified with Agencourt AMPure XP (Beckman Coulter, Villepinte, France) as described in the 16S Metagenomic Sequencing Library Preparation guide . Each sample was run on Agilent 2100 Bioanalyzer (Agilent, Santa Clara, USA) using Agilent High Sensitivity DNA Kit (Agilent, Santa Clara, USA) following manufacturer’s instructions. PCR products were barcoded using Nextera XT Index Kit (Illumina, Evry, France). The index PCRs were performed as recommended in the 16S Metagenomic Sequencing Library Preparation guide: 3 mins at 95°C denaturation; 8 cycles (94°C for 30 secs, 53°C for 30 secs, and 72°C for 30 secs), and 5 mins at 72°C final elongation before cooling at 4°C. Barcoded PCR products were purified using Agencourt AMPure XP, analysed on Agilent 2100 Bioanalyzer and quantified with Quant-iT PicoGreen dsDNA Assay Kit. Samples were normalized to 4nM and pooled (5μl of each normalized sample) into a library. A sequencing PhiX control (Illumina, Evry, France) was prepared following manufacturer’s instructions. The libraries were sequenced using MiSeq Reagent Kit V3 (2 x 300 bp with the 600-cycle kit, Illumina, Evry, France) on Illumina MiSeq platform (Illumina, Evry, France), and resulted in 115,286; 392,274; 68044 and 196230 sequence reads for V1-V2, V3-V4 16S, ITS1, and ITS2, respectively. Raw data are available on Genbank NCBI NIH (SRA accession number: PRJNA548447; https://www.ncbi.nlm.nih.gov/sra/PRJNA548447).
Taxonomic assignment, diversity and statistical analyses
The generated data were analysed with PyroMIC© (protected software, IDDN FR.001.400018.000.S.P.2014.000.31230) which contains a cleaned fungal and bacterial database created from NCBI sequences. Ultimately, only sequences of >100bp for ITS reads and >150bp for 16S reads, with ≥98.7% and ≥94.5% homology, respectively, and 0.0 e-value were considered for identification at species and genus level . Accordingly, we only retained 93,451; 276,475; 65,112 and 191,349 sequence reads for V1-V2, V3-V4 16S, ITS1, and ITS2, respectively (Table 1).
Rarefaction curves were computed to evaluate the quality of the taxonomic diversity assessment. The fungal and bacterial diversity patterns of samples were compared, at genus level, with the diversity patterns of negative controls for each amplification target. In case of similar profiles, contamination of samples by environmental sources was suspected and the samples were analysed one more time. Diversity indexes (Shannon, Shannon evenness, Simpson, Inverse Simpson, and Chao1) were calculated to compare the homogeneity of the samples in terms of bacterial and fungal microbiota composition. The community structure and the relative abundances of the bacterial and fungal taxa were compared according to the extraction protocol and the amplification targets using SHAMAN software (http://shaman.pasteur.fr/) . The analyses of bacterial and fungal diversities were performed at genus level, as 16S/ITS amplicon sequencing is not sensitive enough to obtain precise identification of all micro-organisms at species level. Normalization of read counts was performed using DESeq2 normalization method . The generalized linear model (GLM) implemented in DESeq2 R package was used to detect differences in abundance of taxa between the extraction protocols (MPE vs. AQE), the 16S (V1-V2 vs. V3-V4), and the ITS (ITS1 vs. ITS2) targets. GLM was computed to include the patient, the extraction protocol, and the amplification target as main effects, in addition to interaction between the extraction and the amplification target. This interaction was useful to model the pairing between successive measurements coming from the same individual. Resulting P-values were adjusted according to Benjamini and Hochberg procedure. Wilcoxon rank-sum test (α = 0.05) was used to compare DNA yield by the extraction protocol type.
Influence of extraction protocol on DNA quantity and quality
Beginning with the same amount (250 ± 10 mg) of respiratory samples, we obtained DNA yields ranging from 0 to 37 ng/ml with MPE and from 15 to 411 ng/ml with AQE. For two samples (P4 and P5), no DNA was extracted with MPE method. On average, AQE method yielded double strand DNA of 4.5 times (fold-range [1.3–11]) higher than MPE (p-value = 0.03), within a shorter technical time (~30 min for AQE vs. ~90 min for MPE), and an equivalent cost. Regarding the quality and purity of the DNA, we did not observe significant RNA contamination using agar electrophoresis of DNA samples. AQE method produced higher rates of single-strand DNA than MPE. However, the 260/280 nm absorbance ratio was similar for both extraction protocols (p-value = 0.40, S1 Table).
Bacterial and fungal culture of the two spiked sputa
The bacterial culture of the two spiked sputa was performed during routine analysis. For both patients, the culture revealed commensal flora without significant pathogens (i.e. pathogens ≥107 CFU/ml as defined in REMIC ).
The fungal culture of the two spiked sputa (P1 and P2) revealed the presence of six fungi for P1 (Fig 2): 104CFU/ml of Candida krusei (teleomorph name: Pichia kudriavzevii); 7x103 CFU/ml of Candida albicans; 7x103 of Candida glabrata (of Nakaseomyces genus); 5x102 CFU/ml of Saccharomyces cerevisiae; 6x102 CFU/ml of Aspergillus section Fumigati, and 4x102 CFU/ml of Aspergillus section Nigri. Only three fungi were identified for P2: 2x104 CFU/ml of C. albicans; 2x102 CFU/ml of Aspergillus section Fumigati, and 3x102 CFU/ml Aspergillus section Nigri (Fig 2).
The sputa of P1 and P2 were spiked with 105 CFU/ml of Aspergillus section Nigri and Aspergillus section Fumigati. For ITS targeted amplicon sequencing analysis, DNA was extracted from the respiratory samples using 2 protocols: the automated QIAsymphony extraction [AQE] with DSP DNA midi kit, and the manual PowerSoil® MoBio extraction [MPE]; and amplified by ultra-deep sequencing (MiSeq®, Illumina) using two ITS targets (ITS1 and ITS2). Methods used the same starting quantities of samples and the final volumes were equal. Metagenomic analysis revealed 5 extremely low-represented genera (overall relative abundance < 0.1% for each taxon) which were gathered in “other genera” category: Rhizophlyctis, Schizophyllum, Hanseniaspora, Penicillium, and Inocutis.
Aspergillus DNA detection using qPCR
For the two spiked sputa (P1 and P2), the amount of Aspergillus DNA detected by 28S- and mt-qPCR was comparable (S2 Table) regardless of the extraction protocol.
Bacterial diversity and community structure detected using V1-V2 and V4-V3 16S targeted amplicon sequencing
For P1 spiked-sputum, we analysed 31,274 paired-end reads using V1-V2 region (20,908 and 10,366 reads using MPE and AQE, respectively) and 94,221 reads using V3-V4 (61,552 and 32,669 with MPE and AQE, respectively) (Table 1). For P2 spiked-sputum, we analysed 62,177 reads using V1-V2 (35,055 and 27,122 reads using MPE and AQE, respectively), and 182,254 reads with V3-V4 (113,963 and 68,291 with MPE and AQE, respectively) (Table 1). For every event (2 patients x 2 extraction protocols x 2 amplification targets), the curves reached a plateau, indicating that the bacterial diversity had been satisfactorily detected (S1 Fig). The diversity patterns observed for every condition were different from negative controls and no sample had suffered from environmental contamination (S3 Table). Overall, 43 taxa were identified at genus level and one additional taxon (“Unidentified bacteria”) gathered unclassified reads. Even though a higher number of taxa were detected in P1’s samples (37 taxa vs. 21 in P2’s samples), P1 airway microbiota was less even than P2. Of more, P1 had one vastly predominant taxon (Lactobacillus, overall and per sample relative abundance is >95%), six minor taxa (Streptococcus, Prevotella, Phocaeicola, Olsenella, Mycoplasma, Capnocytophaga; overall relative abundances range from 0.1% to 1%), and 30 extremely low-represented taxa (overall relative abundance < 0.1%) (Fig 3). In contrast, P2 had a more even airway microbiota of six major taxa (Lactobacillus, Streptococcus, Veillonella, Rothia, Prevotella, Enterococcus; overall and per sample relative abundance is >1%), three minor taxa (Haemophilus, Fusobacterium, Campylobacter; overall relative abundances vary from 0.1% to 1%), and 12 extremely low-represented taxa (overall relative abundance <0.1%) (Fig 3). Altogether, 16 bacterial taxa were found in both P1 and P2. Of those, Lactobacillus was identified as the only “core” taxon (> 1% abundance in every tested sample), and five major taxa were dominant in P2 (Streptococcus, Veillonella, Rothia, Prevotella, Enterococcus). If both methods were able to detect 6/6 major and 7/9 minor taxa, we noticed that with V3-V4 a bigger number of extremely low-represented taxa were detected (15 for P1 and 9 for P2). In contrast, only 2 extremely low-represented taxa were detected with V1-V2 exclusively. We also observed that 11 genera were detected with significantly higher relative abundances using V3-V4 than V1-V2 (Prevotella, Phocaeicola, Lactobacillus, and Mycoplasma, p-values <0.001; Streptococcus and Campylobacter, 0.001<p-values<0.01; Fusobacterium, Pseudomonas, Olsenella, Treponema, Rothia, 0.01<p-values<0.05; S2 Fig; S4 Table). Pooled Chao1 index was higher for V3-V4 (50.7) than for V1-V2 (29.7).
DNA was extracted using 2 protocols: the automated QIAsymphony extraction [AQE] with DSP DNA midi kit, and the manual PowerSoil® MoBio extraction [MPE]; and amplified by ultra-deep sequencing (MiSeq®, Illumina) using two 16S targets (V1-V2 and V3-V4).
Methods used the same starting quantities of samples and the final volumes were equal. The category “Other genera” gathered 23 bacterial taxa associated with extremely low relative abundances (overall relative abundance < 0.1% for each taxon): Parascardovia, Anaeroglobus, Actinomyces, Howardella, Staphylococcus, Alloprevotella, Pseudoramibacter, Melissococcus, Corynebacterium, Fretibacterium, Stenotrophomonas, Atopobium, Sphingomonas, Acinetobacter, Shuttleworthia, Acidaminococcus, Moraxella, Oribacterium, Delftia, Eubacterium, Lactococcus, Mogibacterium, Chelativorans, and Vagococcus.
Fungal diversity and community structure detected using ITS1 and ITS2 targeted amplicon sequencing
For P1, we analysed 43,758 paired-end reads using ITS1 region (20,926 and 22,832 reads using MPE and AQE, respectively), and 90,239 reads using ITS2 (34,033 and 56,206 with MPE and AQE, respectively) (Table 1). For P2, we analysed 21,354 reads using ITS1 (6,940 and 14,414 reads using MPE and AQE, respectively), and 101,110 reads with ITS2 (23,279 and 77,831 MPE and AQE, respectively) (Table 1). For every event (2 patients x 2 extraction protocols x 2 targets), the rarefaction curves reached a plateau, indicating that the fungal diversity had been satisfactorily detected (S1 Fig). The diversity patterns observed for every condition differed completely from negative controls and no sample had suffered from environmental contamination (S3 Table). Overall, ten taxa were identified at genus level and one taxon gathered unclassified fungal reads (“Unidentified fungi”). As for Aspergillus taxa, we were able to distinguish between Aspergillus Fumigati and Aspergillus Nigri sections. We detected 9/10 and 8/10 of the fungal genera in P1 and P2, respectively, and the 2 Aspergillus sections were detected in both patients (Fig 2). Setting aside the spiked Aspergillus taxa, we observed that P1 harbored a more diverse respiratory mycobiota with four major fungal genera (Candida, Pichia, Nakaseomyces and Saccharomyces; relative abundance of >1% for each event), and four extremely low-represented genera (Rhizophlyctis, Schizophyllum, Hanseniaspora, Inocutis; relative abundance of <0.1% for each event). P2 had a less even mycobiota with only one vastly predominant fungal taxon (Candida, >90% relative abundance for every event), 1 minor taxon (Saccharomyces, overall relative abundance between 0.1 and 1%), and 4 extremely low-represented genera (Nakaseomyces, Pichia, Penicillium and Inocutis; relative abundance <0.1%). We observed that 7/11 genera or sections were detected with significantly higher relative abundances using ITS2 compared with ITS1 (Aspergillus section Fumigati and Saccharomyces, p-values<0.01; Aspergillus section Nigri, Candida, Pichia, Nakaseomyces, Saccharomyces, Inocutis, 0.01<p-values<0.05; S3 Fig, S5 Table). Of note, 41% of the fungal reads were assigned at species level. In particular, 79.8% and 100% of Candida reads from P1 and P2, respectively, were identified with good sequence homology (>97%) as Candida albicans; 89.2% of Pichia reads from P1 were Candida krusei; 61.5% of Nakaseomyces reads from P1 were Candida glabrata, and 99.9% and 100% of Saccharomyces reads from P1 and P2, respectively, were Saccharomyces cerevisiae. Pooled Chao1 index was twice higher for ITS2 (15.4) than for ITS1 (7).
Comparison of bacterial and fungal diversities as detected by extraction protocols, and comparison of fungal diversity as detected by ITS targeted amplicon sequencing and culture
The bacterial community diversity analysed at genus level and estimated by Shannon and Simpson alpha-diversity indexes was comparable for P1 and P2 for the four analysed events (S6 Table). The pooled Chao1 indexes comparing results of MPE vs. AQE methods were similar for bacteria (61.9 vs. 61.3, respectively). The fungal diversity at genus or section level estimated by Shannon and Simpson indexes was also comparable for the four analysed events (S6 Table). The pooled Chao1 indexes comparing overall results of MPE vs. AQE methods were similar for fungi (14.4 vs. 11.5, respectively).
Concerning the taxonomic diversity, both extraction protocols, MPE and AQE, failed in detecting 3 and 9/43 minor bacterial taxa and 1 and 2/11 minor fungal taxa, respectively. Regarding the relative abundances of taxa, the quantity detected was significantly impacted by extraction for 2 major bacterial genera (Lactobacillus, p-value = 0.008 and Rothia, p-value = 0.049) and 4 major fungal genera or sections (Aspergillus section Fumigati and Saccharomyces, p-values<0.001; Candida, p-value = 0.001; Nakaseomyces, p-value = 0.045) (Fig 4, S7 Table). The abundances of half of these taxa (Lactobacillus, Aspergillus section Fumigati, and Nakaseomyces) were higher with AQE, whereas the other half (Rothia, Candida, and Pichia) had their abundances decreased with AQE (Fig 4, S7 Table).
Boxplot of log2 abundances of bacterial (A) and fungal (B) taxa at genus or section level detected with significantly different abundances (P-value < 0.05) according to the employed extraction protocol. DNA was extracted either by manual PowerSoil® MoBio extraction -MPE- [dark blue] or automated QIAsymphony extraction -AQE- using DSP DNA midi kit [light blue].
As for fungal diversity detected by ITS targeted amplicon sequecing and culture (Fig 2), we observed an overall agreement regarding major taxa since both methods detected 6/6 and 3/4 major taxa for P1 and P2, respectively. Only one major taxon, Saccharomyces, was detected in P2 samples by ITS amplicon sequencing but not by culture. All minor taxa (Rhizophlyctis, Schizophyllum, Hanseniaspora, Penicillium, Inocutis) were detected by sequencing only. The relative abundances of the major taxa detected by culture or ITS amplicon sequencing after AQE or MPE varied significantly. For P1, culture and AQE detected similar proportions of three major yeast taxa (Candida, Nakaseomyces, and Pichia). However, Saccharomyces and Aspergillus relative abundances were close in culture and MPE. For P2, the relative abundances of Candida and Aspergillus detected by AQE were closer to that observed in culture than MPE. But AQE detected a higher proportion of Saccharomyces compared with MPE or culture.
In the present study, we compared, simultaneously and under the same conditions, the impact of two DNA extraction protocols (manual PowerSoil MoBio®  and automated QIAsymphony extraction) on the diversity of respiratory bacterial and fungal microbiota assessed by 16S/ITS targeted amplicon sequencing using 2 bacterial (V1-V2 and V3-V4 16S) and 2 fungal (ITS1 and ITS2) amplification targets. Data of bacterial and fungal cultures were available and used to compare with the results of 16S/ITS targeted amplicon sequencing and Aspergillus qPCR. In our work, the use of automated extraction enhanced the DNA yield and quality with better reliability and shorter technical time than the manual protocol. The bacterial and fungal taxonomic diversity detected in respiratory samples was not highly influenced by the extraction protocol (low and moderate effect, respectively), whereas the amplification targets had a significant influence. A higher number of low density microbial communities were detected by V3-V4 16S and ITS2 targets.
Extraction had a significant influence on the yield of total DNA collected. AQE gave higher output (~4.5 times) of double-strand DNA with less heterogeneous results, in shorter technical time (~30 min) and an equivalent cost compared with MPE. We did not differentiate, as most authors, the human DNA yield from the microbiota DNA yield. However, it has been demonstrated that obtaining high total DNA yields is essential for bacterial targeted amplicon sequencing, and even more for fungal sequencing due to the low load of fungal genes in human microbiota [8,13,35]. Costea et al  compared 21 extraction protocols for bacterial intestinal metagenomic analysis and found that mechanical lysis and bead-beating were positively associated with bacterial diversity assessment, and that was of particular importance for efficient DNA extraction from Gram-positive bacteria. Equally, in our study, we were able to detect Gram-positive bacteria, e.g. Streptococcus, after AQE or MPE, indicating sufficient mechanical lysis. Regarding fungi, Huseyin et al  compared five extraction protocols for intestinal mycobiota analysis and observed that only the methods involving bead-beating steps enabled them to extract DNA in adequate quantities to provide further ITS-PCR products to undergo ultra-deep sequencing. Additionally, Vesty et al  compared four extraction protocols for fungal and bacterial oral 16S/ITS targeted amplicon sequecing and reported, as Sohrabi or Lazarevic did [36,37], that protocols comprising enzymatic lysis steps enhanced the extraction of DNA from the saliva. On the other hand, Rosenbaum et al  compared eight extraction protocols from oral rinse specimens for fungal and bacterial 16S/ITS targeted amplicon sequencing and found that DNA extraction methods had an important influence on overall DNA yield but no significant impact on oral microbiome composition. In their study, as in ours, the authors demonstrated that inter-individual variability drove wider fungal and bacterial diversity variations than did the extraction protocols .
We noticed that the choice of MPE or AQE protocol had only a moderate impact on the diversity and relative abundances of bacterial taxa detected in respiratory samples (2/43 taxa impacted in terms of relative abundance). Other authors [14,37,38] compared extraction protocols for the assessment of bacterial diversity in the upper respiratory tract microbiota and reported a high degree of congruence of the bacterial community structure irrespective of the employed extraction protocol. However, they noticed significant differences in the detection (presence/absence) of very-low abundance taxa and also in the relative abundances of a few major taxa. For instance, Lazarevic et al  and Biesbroek et al  showed that the relative abundances of Firmicutes and Actinobacteria were modified depending on the extraction method. Moreover, Lazarevic et al  observed that Firmicutes taxa were more highly represented in mechanically-treated samples, whereas Actinobacteria taxa were more highly represented in enzymatically-treated samples. In our study, the two bacterial taxa significantly impacted in terms of relative abundance were Lactobacillus (Firmicutes), which showed reduced abundance after AQE (despite the mechanical lysis), and Rothia (Actinobacteria) which had increased abundance after AQE (with an enzymatic lysis step). Overall, the moderate impact of the extraction protocols on the bacterial diversity in respiratory samples contrasts with results on samples from intestinal microbiota. In the gut, the extraction appears to highly influence the diversity and relative abundances of bacterial taxa [6,8]. This contrast might be explained by the lower diversity of the respiratory microbiota compared with the intestinal one, with maybe fewer bacterial taxa difficult to extract from respiratory samples. Interestingly, in our study, the use of AQE or MPE had a more significant impact on fungal communities (4/11 taxa impacted in term of relative abundance). Furthermore, we could not observe a recurrent pattern of decreased or increased relative abundances for these four taxa in relation with the protocol. To our knowledge, only Vesty et al  conducted a similar study comparing the fungal diversity of the upper respiratory tract and dental plaque in relation with extraction protocol. In their work, they did not document significant differences in the fungal communities from dental plaque but the plaque microbiota presented a very low diversity (>99% of Candida). In the saliva, 3/4 extraction protocols failed to yield an adequate number of reads to properly assess the fungal diversity. In our work, we also compared the fungal diversity assessed by ITS targeted amplicon sequencing using AQE or MPE versus culture results. In the literature, few studies have performed such comparison for fungal respiratory microbiota . We confirm that amplicon sequencing detected more fungal taxa than culture. Taxa undetected by culture were mainly very-low represented taxa in addition to one major taxa, Saccharomyces. Concerning the relative abundances of major fungal taxa detected in our samples (Aspergillus, Candida, Pichia, Nakaseomyces, and Saccharomyces), the proportions detected by sequecing after AQE were closer to culture results, especially for Candida, Pichia, and Nakaseomyces genera. However, we do not know whether culture results reflect the exact image of the composition/abundance of the respiratory fungal (or bacterial) microbiota.
The choice of the 16S or ITS primer sets used for targeted amplicon sequencing has a significant influence on the bacterial and fungal taxonomic diversity assessment. This is particularly visible for low density microbial communities. We detected more bacterial diversity, and particularly more extremely low-represented taxa using the 16S V3-V4 compared with V1-V2. Moreover, the relative abundances of 11/43 bacterial taxa were higher with the 16S V3-V4 target compared with V1-V2. Such results were somehow expected since V3-V4 primers had already been described by Klindworth et al as suitable for Illumina sequencing thanks to their high overall coverage associated with good domain specificity . Clooney et al , in a study comparing three different high throughput sequencing technologies and two 16S region targets (V1-V2 and V4-V5), already observed that the primers they (like us) used for V1-V2 on Illumina MiSeq® were associated with the detection of a smaller number of species compared with other primers. For fungi, we detected more very low abundance fungal taxa with ITS2 than ITS1, with increased relative abundances in 7/11 fungal taxa using ITS2 compared with ITS1. The choice between ITS1 and ITS2 to study the fungal diversity in various microbiota remains undetermined to date. Different studies have compared both targets [22,39–42] but their results are not concordant. Wang et al  conducted a meta-analysis comparing both targets for eukaryotic analysis and discovered that ITS1 was superior to ITS2. They showed that ITS1 performed better in terms of successful amplification rates for a big number of eukaryotic species (due to lower GC content) and that the overall identification success rate was higher (especially for ferns, gymnosperms and ascomycetes). Inversely, other authors [22,39,40,43], who discussed this issue specifically for fungal analysis, did not demonstrate clear superiority of one target over the other. Blaalid et al  noticed comparable taxonomic composition at phylum and order level and some discrepancies on both sides (ITS1 and ITS2) at genus level. Bellemain et al  reported selective amplification biases associated with primers: the ITS1-F primer was biased towards basidiomycetes, while ITS2, ITS3, or ITS4 primers were biased towards ascomycetes . Usyk et al  suggested that ITS1-F and ITS2 primers might not be appropriate for targeted amplicon sequencing and proposed new customized primers for ITS1 region. Ali et al , who worked specifically on respiratory specimen, found that amplification of ITS2 region was more accurate compared to ITS1. Finally, as both ITS targets have their advantages, several authors suggest using them concomitantly and then gather complementary information [22,40,43]. De Filippis et al  even hypothesised that targeting the ITS region only may lead to incorrect assessment of fungal communities. He suggested using other targets located on different genome regions in sequencing-based microbiota studies.
The microbiota profiles seen in our two patients were remarkably different, as often in sequencing-based microbiota analyses. P1 presented a very low bacterial diversity profile (one vastly predominant taxon, Lactobacillus) associated with a more diverse fungal profile (four major yeast taxa, Candida, Pichia, Nakaseomyces, and Saccharomyces). P2 had the inverse pattern: more bacterial diversity (six major taxa, Streptococcus, Veillonella, Rothia, Prevotella, Lactobacillus, and Enterococcus) and only one predominant fungal taxon (Candida). The major bacterial taxa identified in P2 (especially Streptococcus, Veillonella, and Prevotella) are known to be usual inhabitants of the upper respiratory tract of healthy humans [1,14,46,47], which is concordant with P2 status as a patient hospitalized for surgery without comorbidities. On the contrary, the very low-bacterial diversity profile of P1 was less usual, but this may be due to the immunocompromised status and the broad-spectrum antibacterial medicines received by that patient. Similar to the findings of other authors working on upper respiratory tract samples [14,19,48,49], we detected in both patients a predominance of yeasts: Candida (mainly Candida albicans), Pichia (mainly Candida krusei), Nakaseomyces (mainly Candida glabrata), and Saccharomyces (mainly Saccharomyces cerevisiae). However, and in contrast with data from the literature [14,48,49], we did not find reads assigned as Malassezia. This might be related to the extraction protocols we tested. Dupuy et al  explained that Malassezia species are known to have thick cell walls, hence the need for a harsh extraction protocol. The mechanical (with enzymatic or chemical lysis) used in AQE or MPE might not be strong enough to detect Malassezia reads. As for moulds taxa, we did not find significant genera other than Aspergillus, which were spiked in P1 and P2 sputa.
The main limitation of our study was the small number of samples analysed and the fact that we did not perform technical replications for the different conditions tested. However, in the emerging field of combined bacterial and fungal airway microbiota analysis, data regarding technical issues associated with extraction protocols or choice of primer sets are still scarce [14,15] and our results might still provide valuable information for other authors.
Another difficulty experienced in our study was that we were not able to extract, quantify or purify specifically human vs. bacterial or fungal DNA. This fact may introduce a potential bias in the quantification of our libraries prior sequencing. The presence of host DNA might thus decrease the depth of bacterial or fungal reads’ sequencing. However, to our knowledge, no satisfactory methods are yet available to specifically extract, purify or even quantify microbial DNA vs. host DNA with good reliability. To overcome the potential challenges associated with this issue, different strategies have been implemented in microbiota studies. First, when designing a targeted amplicon sequencing analysis, it is important to adapt the number of samples sequenced in each run in order to get a good sequencing depth for every sample and especially for microbial reads. Second, the bioinformatics pipelines applied to the raw data obtained after sequencing include a filtering process consisting in the removal of almost all reads assigned as human DNA. Over the past years, these bioinformatics pipelines have greatly improved and filtering process is now very efficient and stringent to remove host DNA. The filtered data are afterwards clustered and assigned to microbial taxa and finally the relative abundances of microbial taxa are compared between samples. These bioinformatics procedures allow us to limit the potential biases associated with the presence of host contaminant reads in various quantity from one sample to another. Also, an accurate representation of the microbial diversity within a sample can be detected, provided that the overall yield of DNA extracted at the beginning of the procedure was high enough [8,13].
Given that technical issues can influence the understanding of microbial communities, selecting protocols suitable for the characterization of the sputa microbiota is necessary to allow inter-study comparisons. Although our study included a small number of subjects, we observed that the use of an automated protocol (such as QIAsymphony) including both mechanical and enzymatic lysis enhanced the DNA extraction yield with more reliability and less technical time. Otherwise, the choice of extraction did not highly influence the bacterial or fungal taxonomic diversity detected in respiratory samples (low and moderate effect, respectively). In contrast, the choice of primer sets for targeted amplicon sequencing significantly influenced the bacterial and fungal diversity detected. In particular, we observed that V3-V4, 16S and ITS2 targets allowed to detect an increased number of low density microbial communities. Finally, for further 16S/ITS targeted amplicon sequencing on respiratory bacterial and fungal microbiota, we will choose to use the above described automated protocol and prefer the ITS2 target or, if possible, combine ITS1 and ITS2.
Rarefaction curves of bacterial (A) and fungal (B) diversity identified from total DNA extracted from respiratory samples of 2 patients (P1, P2) using two extraction protocols (Automatic QIAsymphony Extraction [AQE, blue] with DSP DNA midi kit and Manual PowerSoil® Extraction [MPE, red]) and targeting 2 16S regions for bacterial analysis (V1-V2, solid line; V3-V4, dotted line) and 2 ITS regions for fungal analysis (ITS1, solid line; ITS2, dotted line).
Boxplot of log2 abundances of bacterial genera detected with significantly different abundances (P-value < 0.05) when amplified using either V1-V2 16S target [dark blue] or V3-V4 16S target [light blue].
Boxplot of log2 abundances of fungal genera or sections detected with significantly different abundances (P-value < 0.05) when amplified using either ITS1 target [dark blue] or ITS2 target [light blue].
S1 Table. Results of DNA extractions from 6 respiratory samples (taken from 6 patients, P1 to P6) using two extraction protocols (Automated QIAsymphony Extraction [AQE] with DSP DNA midi kit and Manual PowerSoil® Extraction [MPE]).
The DNA was quantified (ng/ml) using Picogreen® dosage and its quality was determined using 260/280 purity ratio (Nanodrop®).
S2 Table. Semi-quantitative detection of Aspergillus DNA extracted using two extraction protocols from respiratory samples of 2 patients (P1, P2).
The extraction protocols used were the Automated QIAsymphony Extraction [AQE] with DSP DNA midi kit, and the Manual PowerSoil® Extraction [MPE]. The 2 sputa were spiked with 105 conidia/ml of Aspergillus section Fumigati and Aspergillus section Nigri.
S3 Table. Diversity profiles (expressed in relative abundances at genus level) of negative controls according to sequencing amplification targets (16S V1-V2, 16S V3-V4, ITS1 and ITS2).
S4 Table. Abundance Fold Change (expressed as log2 Fold Change) of bacterial genera significantly different (P-value < 0.05) with regard to the employed 16S target of amplification (V1-V2 vs. V3-V4).
S5 Table. Abundance Fold Change (expressed as log2 Fold Change) of fungal genera or sections significantly different (P-value < 0.05) with regards to the used ITS target of amplification (ITS1 vs. ITS2).
Alpha diversity measurements (Shannon, Simpson, and Chao1 indexes) for bacterial (A) and fungal (B) targeted amplicon sequencing analyses performed on respiratory samples of 2 patients (P1 and P2). DNA was extracted using two extraction protocols (Automated QIAsymphony Extraction [AQE] with DSP DNA midi kit, and Manual PowerSoil® Extraction [MPE]). Amplification targets used were VI-V2 and V3-V4 for bacterial analysis and ITS1 and ITS2 for fungal analysis.
Abundance Fold Change (expressed as log2 Fold Change) of bacterial (A) and fungal (B) taxa significantly different (P-value < 0.05) with regard to the used extraction protocol (manual PowerSoil® MoBio extraction [MPE] vs. automated QIAsymphony extraction [AQE]).
We thank Vanessa Demontant for her precious help regarding all high-throughput sequencing technical steps and Guillaume Gricourt for his help with the data analysis. We thank Stephanie Ferreira from Genoscreen and Laurence Delhaes for their advice on technical and analysis issues. We thank Dr Suhad Assad for her critical linguistic reviewing.
- 1. Bassis CM, Erb-Downward JR, Dickson RP, Freeman CM, Schmidt TM, Young VB, et al. Analysis of the Upper Respiratory Tract Microbiotas as the Source of the Lung and Gastric Microbiotas in Healthy Individuals. mBio. 2015;6. pmid:25736890
- 2. Botterel F, Angebault C, Cabaret O, Stressmann FA, Costa J-M, Wallet F, et al. Fungal and Bacterial Diversity of Airway Microbiota in Adults with Cystic Fibrosis: Concordance Between Conventional Methods and Ultra-Deep Sequencing, and Their Practical use in the Clinical Laboratory. Mycopathologia. 2017. pmid:28766039
- 3. Delhaes L, Monchy S, Frealle E, Hubans C, Salleron J, Leroy S, et al. The Airway Microbiota in Cystic Fibrosis: A Complex Fungal and Bacterial Community—Implications for Therapeutic Management. PLoS ONE. 2012;7. pmid:22558432
- 4. Huang YJ, LiPuma JJ. The Microbiome in Cystic Fibrosis. Clin Chest Med. 2016;37: 59–67. pmid:26857768
- 5. Tipton L, Ghedin E, Morris A. The lung mycobiome in the next-generation sequencing era. Virulence. 2016;8: 334–341. pmid:27687858
- 6. Angebault C, Ghozlane A, Volant S, Botterel F, d’Enfert C, Bougnoux M-E. Combined bacterial and fungal intestinal microbiota analyses: Impact of storage conditions and DNA extraction protocols. PLoS ONE. 2018;13: e0201174. pmid:30074988
- 7. Clooney AG, Fouhy F, Sleator RD, O’ Driscoll A, Stanton C, Cotter PD, et al. Comparing Apples and Oranges?: Next Generation Sequencing and Its Impact on Microbiome Analysis. PLoS One. 2016;11. pmid:26849217
- 8. Costea PI, Zeller G, Sunagawa S, Pelletier E, Alberti A, Levenez F, et al. Towards standards for human fecal sample processing in metagenomic studies. Nat Biotechnol. 2017;35: 1069–1076. pmid:28967887
- 9. Dominianni C, Wu J, Hayes RB, Ahn J. Comparison of methods for fecal microbiome biospecimen collection. BMC Microbiol. 2014;14: 103. pmid:24758293
- 10. Fouhy F, Deane J, Rea MC, O’Sullivan Ó, Ross RP, O’Callaghan G, et al. The Effects of Freezing on Faecal Microbiota as Determined Using MiSeq Sequencing and Culture-Based Investigations. PLoS One. 2015;10. pmid:25748176
- 11. Wen Y, Xiao F, Wang C, Wang Z. The impact of different methods of DNA extraction on microbial community measures of BALF samples based on metagenomic data. Am J Transl Res. 2016;8: 1412–1425. pmid:27186268
- 12. Dollive S, Peterfreund GL, Sherrill-Mix S, Bittinger K, Sinha R, Hoffmann C, et al. A tool kit for quantifying eukaryotic rRNA gene sequences from human microbiome samples. Genome Biol. 2012;13: R60. pmid:22759449
- 13. Huseyin CE, Rubio RC, O’Sullivan O, Cotter PD, Scanlan PD. The Fungal Frontier: A Comparative Analysis of Methods Used in the Study of the Human Gut Mycobiome. Front Microbiol. 2017;8. pmid:28824566
- 14. Vesty A, Biswas K, Taylor MW, Gear K, Douglas RG. Evaluating the Impact of DNA Extraction Method on the Representation of Human Oral Bacterial and Fungal Communities. PLoS ONE. 2017;12. pmid:28099455
- 15. Rosenbaum J, Usyk M, Chen Z, Zolnik CP, Jones HE, Waldron L, et al. Evaluation of Oral Cavity DNA Extraction Methods on Bacterial and Fungal Microbiota. Sci Rep. 2019;9: 1531. pmid:30728424
- 16. Free SJ. Fungal cell wall organization and biosynthesis. Adv Genet. 2013;81: 33–82. pmid:23419716
- 17. Karakousis A, Tan L, Ellis D, Alexiou H, Wormald PJ. An assessment of the efficiency of fungal DNA extraction methods for maximizing the detection of medically important fungi using PCR. J Microbiol Methods. 2006;65: 38–48. pmid:16099520
- 18. Schoch CL, Seifert KA, Huhndorf S, Robert V, Spouge JL, Levesque CA, et al. Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi. Proc Natl Acad Sci U S A. 2012;109: 6241–6246. pmid:22454494
- 19. Ghannoum MA, Jurevic RJ, Mukherjee PK, Cui F, Sikaroodi M, Naqvi A, et al. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog. 2010;6: e1000713. pmid:20072605
- 20. Findley K, Oh J, Yang J, Conlan S, Deming C, Meyer JA, et al. Topographic diversity of fungal and bacterial communities in human skin. Nature. 2013;498: 367–370. pmid:23698366
- 21. Iliev ID, Funari VA, Taylor KD, Nguyen Q, Reyes CN, Strom SP, et al. Interactions Between Commensal Fungi and the C-Type Lectin Receptor Dectin-1 Influence Colitis. Science. 2012;336: 1314–1317.
- 22. Hamad I, Sokhna C, Raoult D, Bittar F. Molecular Detection of Eukaryotes in a Single Human Stool Sample from Senegal. PLoS One. 2012;7. pmid:22808282
- 23. Murray PR, Washington JA. Microscopic and baceriologic analysis of expectorated sputum. Mayo Clin Proc. 1975;50: 339–344. pmid:1127999
- 24. Challier S, Boyer S, Abachin E, Berche P. Development of a serum-based Taqman real-time PCR assay for diagnosis of invasive aspergillosis. J Clin Microbiol. 2004;42: 844–846. pmid:14766869
- 25. Bretagne S, Costa JM, Marmorat-Khuong A, Poron F, Cordonnier C, Vidaud M, et al. Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR. J Clin Microbiol. 1995;33: 1164–1168. pmid:7615723
- 26. Klindworth A, Pruesse E, Schweer T, Peplies J, Quast C, Horn M, et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res. 2013;41: e1. pmid:22933715
- 27. Illumina. 16S Metagenomic Sequencing Library Preparation. 2014. Available: http://emea.support.illumina.com/downloads/16s_metagenomic_sequencing_library_preparation.html#
- 28. Cui L, Morris A, Ghedin E. The human mycobiome in health and disease. Genome Med. 2013;5: 63. pmid:23899327
- 29. Gardes M, Bruns TD. ITS primers with enhanced specificity for basidiomycetes—application to the identification of mycorrhizae and rusts. Molecular Ecology. 1993;2: 113–118. pmid:8180733
- 30. White TJ, Bruns L, Lee S, Taylor J. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. PCR Protocols: A Guide to Methods and Applications. New York: Academic Press; 1990. pp. 315–322.
- 31. Yarza P, Yilmaz P, Pruesse E, Glöckner FO, Ludwig W, Schleifer K-H, et al. Uniting the classification of cultured and uncultured bacteria and archaea using 16S rRNA gene sequences. Nat Rev Microbiol. 2014;12: 635–645. pmid:25118885
- 32. Quereda JJ, Dussurget O, Nahori M-A, Ghozlane A, Volant S, Dillies M-A, et al. Bacteriocin from epidemic Listeria strains alters the host intestinal microbiota to favor infection. Proc Natl Acad Sci U S A. 2016;113: 5706–5711. pmid:27140611
- 33. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15. pmid:25516281
- 34. Infections broncho-pulmonaires. 5e édition. REMIC Référentiel en microbiologie médicale. 5e édition. Société Française de Microbiologie Ed.; 2015. Available: https://www.decitre.fr/livres/remic-2015-9782878050325.html
- 35. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464: 59–65. pmid:20203603
- 36. Sohrabi M, Nair RG, Samaranayake LP, Zhang L, Zulfiker AHMd, Ahmetagic A, et al. The yield and quality of cellular and bacterial DNA extracts from human oral rinse samples are variably affected by the cell lysis methodology. Journal of Microbiological Methods. 2016;122: 64–72. pmid:26812577
- 37. Lazarevic V, Gaïa N, Girard M, François P, Schrenzel J. Comparison of DNA Extraction Methods in Analysis of Salivary Bacterial Communities. PLoS One. 2013;8. pmid:23844068
- 38. Biesbroek G, Sanders EAM, Roeselers G, Wang X, Caspers MPM, Trzciński K, et al. Deep Sequencing Analyses of Low Density Microbial Communities: Working at the Boundary of Accurate Microbiota Detection. PLoS One. 2012;7. pmid:22412957
- 39. Blaalid R, Kumar S, Nilsson RH, Abarenkov K, Kirk PM, Kauserud H. ITS1 versus ITS2 as DNA metabarcodes for fungi. Molecular Ecology Resources. 2013;13: 218–224. pmid:23350562
- 40. Monard C, Gantner S, Stenlid J. Utilizing ITS1 and ITS2 to study environmental fungal diversity using pyrosequencing. FEMS Microbiol Ecol. 2013;84: 165–175. pmid:23176677
- 41. Wang X-C, Liu C, Huang L, Bengtsson-Palme J, Chen H, Zhang J-H, et al. ITS1: a DNA barcode better than ITS2 in eukaryotes? Mol Ecol Resour. 2015;15: 573–586. pmid:25187125
- 42. Ali NABM, Mac Aogáin M, Morales RF, Tiew PY, Chotirmall SH. Optimisation and Benchmarking of Targeted Amplicon Sequencing for Mycobiome Analysis of Respiratory Specimens. Int J Mol Sci. 2019;20. pmid:31601001
- 43. Bellemain E, Carlsen T, Brochmann C, Coissac E, Taberlet P, Kauserud H. ITS as an environmental DNA barcode for fungi: an in silico approach reveals potential PCR biases. BMC Microbiol. 2010;10: 189. pmid:20618939
- 44. Usyk M, Zolnik CP, Patel H, Levi MH, Burk RD. Novel ITS1 Fungal Primers for Characterization of the Mycobiome. mSphere. 2017;2. pmid:29242834
- 45. De Filippis F, Laiola M, Blaiotta G, Ercolini D. Different Amplicon Targets for Sequencing-Based Studies of Fungal Diversity. Appl Environ Microbiol. 2017;83. pmid:28625991
- 46. Charlson ES, Bittinger K, Haas AR, Fitzgerald AS, Frank I, Yadav A, et al. Topographical Continuity of Bacterial Populations in the Healthy Human Respiratory Tract. Am J Respir Crit Care Med. 2011;184: 957–963. pmid:21680950
- 47. Lim MY, Yoon HS, Rho M, Sung J, Song Y-M, Lee K, et al. Analysis of the association between host genetics, smoking, and sputum microbiota in healthy humans. Scientific Reports. 2016;6. pmid:27030383
- 48. Willger SD, Grim SL, Dolben EL, Shipunova A, Hampton TH, Morrison HG, et al. Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis. Microbiome. 2014;2: 40. pmid:25408892
- 49. Dupuy AK, David MS, Li L, Heider TN, Peterson JD, Montano EA, et al. Redefining the Human Oral Mycobiome with Improved Practices in Amplicon-based Taxonomy: Discovery of Malassezia as a Prominent Commensal. PLoS One. 2014;9. pmid:24614173